Addressing a serious electrical disorder of the heart, Long QT Syndrome, Mayo Clinic is developing a potentially life-saving device for early detection.

There are several forms of Long QT, ranging in severity and cause.  Some known causes are:

  • More than 100 drugs approved by the Food and Drug Administration (FDA).
  • Genetics, including congenital long QT syndrome.
  • Many systemic diseases, including even SARS-CoV-2-mediated COVID-19.

Original article

Mayo Clinic research yields breakthrough in mobile determination of QT prolongation


ROCHESTER, Minn. — Researchers from Mayo Clinic and AliveCor Inc. have been using artificial intelligence (AI) to develop a mobile device that can identify certain patients at risk of sudden cardiac death.  This research has yielded a breakthrough in determining the health of the electrical recharging system in a patient’s heart. The researchers determined that a smartphone-enabled mobile EKG device can rapidly and accurately determine a patient’s QTc, thereby identifying patients at risk of sudden cardiac death from congenital long QT syndrome (LQTS) or drug-induced QT prolongation.

Read the entire article 

Share this article

Share on facebook
Share on twitter
Share on linkedin

Leave a Reply

Your email address will not be published. Required fields are marked *

Kulman, LLC © All Rights Reserved 2020

Take a short questionnaire to determine if a HeartCheck is right for your child?